Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
University of California San Francisco
Give to UCSFScientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
Take a look back at UCSF's most popular stories of 2020 - a chronicle of an extraordinary year.
Expanding routine newborn screening to include a metabolic vulnerability profile could lead to earlier detection of life-threatening complications in babies born preterm, according to a study by UC San Francisco researchers.
With influenza, COVID-19, and the usual cold-weather respiratory infections in circulation this winter, experts say it’s bound to be a confusing season for people to sort out what to do when they fall ill.
A new video offers a roadmap for structured meetings between clinicians and family members when a patient has a serious or life-threatening condition.
A new study from UCSF Benioff Children’s Hospitals suggests that for some hospitals, video visits may become a permanent feature of the patient-provider landscape.
Amid so little good news, early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. But the newest obstacle may be the uncertainty that surrounds how the drug will be distributed to patients.